KATHLEEN MORRIS: Open Payments
NPI 1164708392 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 31 payments from 10 companies in 2025. Trend: 2023 $492 · 2024 $616 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $184 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $117 |
| Biogen, Inc. | 4 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| ABBVIE INC. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Organon LLC | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Exeltis, USA Inc. | 1 | $21 |
| Amgen Inc. | 1 | $17 |
Products named: Veozah, ZURZUVAE, MYFEMBREE, LILETTA, NEXPLANON, Exparel, SLYND, Lynkuet.
Industry payments across NE — which companies pay providers there.
